PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 137 filers reported holding PDL BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,136,000 | -7.5% | 360,775 | -14.5% | 0.00% | 0.0% |
| Q2 2020 | $1,228,000 | -0.6% | 422,069 | -3.6% | 0.00% | -25.0% |
| Q1 2020 | $1,235,000 | -29.0% | 437,957 | -18.3% | 0.00% | 0.0% |
| Q4 2019 | $1,740,000 | +31.2% | 536,069 | -12.7% | 0.00% | +33.3% |
| Q3 2019 | $1,326,000 | -32.9% | 614,053 | -2.5% | 0.00% | -40.0% |
| Q2 2019 | $1,977,000 | -17.4% | 629,612 | -2.2% | 0.01% | -16.7% |
| Q1 2019 | $2,394,000 | +11.2% | 643,617 | -13.3% | 0.01% | 0.0% |
| Q4 2018 | $2,153,000 | -8.7% | 742,444 | -17.2% | 0.01% | 0.0% |
| Q3 2018 | $2,359,000 | -15.6% | 896,986 | -24.9% | 0.01% | -25.0% |
| Q2 2018 | $2,794,000 | -26.1% | 1,193,987 | -7.1% | 0.01% | -27.3% |
| Q1 2018 | $3,779,000 | -8.3% | 1,285,522 | -14.5% | 0.01% | -8.3% |
| Q4 2017 | $4,120,000 | -21.5% | 1,503,710 | -2.9% | 0.01% | -20.0% |
| Q3 2017 | $5,248,000 | +47.0% | 1,548,080 | +7.1% | 0.02% | +50.0% |
| Q2 2017 | $3,570,000 | +14.7% | 1,445,412 | +5.4% | 0.01% | +11.1% |
| Q1 2017 | $3,112,000 | +28.9% | 1,370,853 | +20.4% | 0.01% | +28.6% |
| Q4 2016 | $2,414,000 | -21.8% | 1,138,773 | +23.6% | 0.01% | -22.2% |
| Q3 2016 | $3,087,000 | +1.0% | 921,458 | -5.3% | 0.01% | 0.0% |
| Q2 2016 | $3,055,000 | -2.0% | 972,933 | +3.9% | 0.01% | -10.0% |
| Q1 2016 | $3,117,000 | +31.7% | 936,045 | +40.0% | 0.01% | +42.9% |
| Q4 2015 | $2,366,000 | +44.5% | 668,419 | +105.4% | 0.01% | +40.0% |
| Q3 2015 | $1,637,000 | +11.0% | 325,418 | +41.9% | 0.01% | +25.0% |
| Q2 2015 | $1,475,000 | -89.2% | 229,387 | -87.0% | 0.00% | -90.5% |
| Q4 2014 | $13,648,000 | +3.3% | 1,770,133 | +0.1% | 0.04% | -2.3% |
| Q3 2014 | $13,212,000 | +39.6% | 1,768,613 | +80.9% | 0.04% | +43.3% |
| Q2 2014 | $9,464,000 | +180.3% | 977,709 | +140.7% | 0.03% | +172.7% |
| Q1 2014 | $3,376,000 | +5015.2% | 406,215 | +5093.2% | 0.01% | – |
| Q4 2013 | $66,000 | -4.3% | 7,822 | -9.3% | 0.00% | – |
| Q3 2013 | $69,000 | -38.9% | 8,628 | -40.8% | 0.00% | – |
| Q2 2013 | $113,000 | – | 14,583 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |